The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...

Researchers at the Karolinska Institute continue to investigate whether gene therapy can improve vision in people with ...

The Cell & Gene Therapy Manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

The team engineered genes to code for the RING constructs and delivered them to mice using an adenovirus vector, commonly ...

A team of researchers report findings from a Phase I/II gene therapy clinical trial for patients with Leber congenital ...

Delve into Vironexis' launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...